Page last updated: 2024-12-08

substance p (1-4)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

substance P (1-4): N-terminal tetrapeptide fragment of substance P [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID172406
CHEMBL ID3277520
MeSH IDM0125734

Synonyms (10)

Synonym
sp(1-4)
(2s)-n-[(2s)-6-amino-1-[(2s)-2-carbamoylpyrrolidin-1-yl]-1-oxohexan-2-yl]-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carboxamide
substance p (1-4)
69355-89-1
arginyl-prolyl-lysyl-prolinamide
CHEMBL3277520
DTXSID10219444
AKOS030531750
(s)-1-(l-arginyl)-n-((s)-6-amino-1-((s)-2-carbamoylpyrrolidin-1-yl)-1-oxohexan-2-yl)pyrrolidine-2-carboxamide
(s)-n-((s)-6-amino-1-((s)-2-carbamoylpyrrolidin-1-yl)-1-oxohexan-2-yl)-1-((s)-2-amino-5-guanidinopentanoyl)pyrrolidine-2-carboxamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1150938Increase in femoral blood flow in morphine pretreated mongrel dog assessed as potency treated into femoral artery relative to substance P1976Journal of medicinal chemistry, Jun, Volume: 19, Issue:6
Biological activity of C-terminal partial sequences of substance P.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (75.00)18.7374
1990's3 (18.75)18.2507
2000's1 (6.25)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.82 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.03 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]